Search Press releases Keywords From To 15 Sep 2006 UCB Awards Professorial Chair in Management of Inflammatory Bowel Disease at the Katholieke Universiteit Leuven, Belgium Read More 23 Aug 2006 FDA Approves Keppra® as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Read More 21 Aug 2006 UCB Announces Agreement with Verus Pharmaceuticals for Commercialization of Twinject® in Europe Read More 18 Aug 2006 Key Approval for Keppra® Offers New Treatment Option for Newly Diagnosed Epilepsy Patients Read More 2 Aug 2006 FDA Approves Keppra® Intravenous Formulation Read More 27 Jul 2006 UCB First Half-Year 2006 Financial Results Read More Pagination First page Previous page Previous … Page 185 Page 186 Page 187 Page 188 Current page 189 Page 190 Page 191 Page 192 Page 193 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
